. MIH is effective in reducing elevated intracranial pressure (ICP) in TBI [1] . In addition to controlling intracranial hypertension, optimizing partial brain oxygen tension (PbtO 2 ) may also decrease morbidity in TBI patients [2] . PbtO 2 is often used in conjunction with monitoring ICP and brain temperature to tailor hemodynamic management in patients with acute traumatic brain injuries [3] . Normal PbtO 2 values for brain tissue oxygen varies from 25 to 35 mmHg. Values lower than <20 mmHg indicate inadequate brain tissue oxygenation and perfusion [3] . Risk of morbidity and mortality in TBI has shown to significantly increase with values <15 mmHg [3] . Monitoring cerebral oxygenation, perfusion, and brain temperature may identify changes associated with neurological worsening prior to changes in examination [3] . Induced mild hypothermia inhibits multiple pathological processes simultaneously that may attenuate secondary biochemical cascades that are activated after acute ischemic injury through reduction of metabolism, perfusion, and edema. Also, reduction of ICP by MIH may help improve overall perfusion.
However, the significance of PbtO 2 monitoring with MIH is largely unknown. In this study, we have investigated the effects of MIH on concomitantly obtained indices of PbtO 2 and ICP in a patient with severe TBI. In our study, PbtO 2 decreased linearly with the decrease in body temperature. There was a significant reduction in PbtO 2 values as temperature decreased (p<0.001). PbtO 2 reduction was evident even though the ICP did not change with a decrease in temperature and remained elevated (p=0.78), a finding that has not been reported previously. This finding raises concerns about the effectiveness of MIH in lowering ICP in patients with severe TBI who are already in a medically-induced coma.
Case Report
A 23 years old male was brought to the emergency department in an unresponsive condition after sustaining a traumatic head injury. His Glasgow coma scale (GCS) score was 3 (E: 1, V: 1, M: 1) requiring intubation. Vital signs in the emergency department were notable for a blood pressure of
Introduction
Therapeutic temperature modulation with induced mild hypothermia (MIH) exerts neuroprotection and attenuates secondary cerebral insults after traumatic brain injury (TBI) Patients continued to deteriorate with the development of multisystem organ failure. After multi-disciplinary discussions, the family requested transition to comfort care.
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Discussion
MIH is generally an effective intervention in reducing intracranial pressure but can also affect cerebral blood flow and PbtO 2 [4] . In our study, we observed a correlation between PbtO 2 with a decrease in temperature most obvious at temperatures below 34°C. The reduction in PbtO 2 can be explained by several physiological factors:
1. A decrease in body temperature below 37°C is associated with decreased oxygen utilization in the brain [4] .
2. Hypothermia can cause a leftward shift in oxygen distribution curve [5] . This enhances the affinity of oxygen to hemoglobin causing reduced oxygen release and reduced availability to brain cells [5] .
3. The rate of oxygen diffusion is directly proportional to the tension gradient between the vessels and the mitochondria, the conductance through the tissue, and the time available for diffusion [6] . A mismatch in oxygen metabolism/delivery following TBI can be contributed to the microvascular injury, increased diffusion distances following cerebral edema, and mitochondrial alterations secondary to membrane damage [7] .
All the above factors can contribute to decrease oxygen availability, impaired diffusion, and eventual tissue hypoxia.
Studies have investigated the direct effect of hypothermia on PbtO 2 . In a study of 30 patients cooled to a minimum of 33°C. Gupta et al. [8] investigated the effects of decreasing brain temperature on indices of brain parenchymal oxygenation and metabolism in patients with severe head injury [8] . They found no significant change in arterial O 2 , CO 2 , and pH as brain temperature was reduced to 35°C. However, below 35°C, there was a significant reduction in PbtO 2 , which occurred despite an increase in PaO 2 [8] . A retrospective analysis by Flynn et al. [2] studied the effects of therapeutic hypothermia on intracranial pressure and partial brain oxygen tension in patients with severe traumatic brain injury. ICP and PbtO 2 were measured using the Licox system and core temperature was recorded through rectal thermometer [2] . Data were analyzed at the hour before cooling, the first hour at the target temperature, two consecutive hours at the target temperature, and after 6 hours of hypothermia [2] . A mean decrease in ICP of 4.3 ± 1.6 mmHg from pre-cooling to the first epoch of hypothermia was observed [2] . There was also a mean decrease in PbtO 2 of 7.8 ± 3.1 mmHg from pre-cooling to stable hypothermia [2] . In our patient, we observed a decrease of about 30 mmHg in PbtO 2 with a 5 degree Celsius decrease in temperature. The hypothermia protocol was activated for duration of 2 days. The body temperature was reduced from 36.4 to 31.7°C over two days. Graph 2c also represents changes in ICP and PbtO 2 over time. Small microtrauma can possibly occur with licox implantation, however no such variations demonstrating local injury were noted in PbtO 2 readings in our patient. CT head following implantation showed no focal hemorrhage or sign of local tissue damage. The patient developed multiorgan failure over subsequent days following initiation of hypothermia therapy. The creatinine value, which was 1.2 mg/dl at initial presentation deteriorated to 4.88 mg/ dl. Both PbtO 2 and ICP values responded well to hypothermia therapy during the initial phase. However, the possibility of organ failure and decline in tissue oxygenation cannot be ignored given the critical condition of the patient during later half of hypothermia therapy.
If hypothermia consistently decreased tissue oxygenation, it has the potential of causing cerebral ischemia [9] . Unlike many pharmacological treatments that tend to antagonize a single neurochemical process, hypothermia inhibits multiple pathological processes simultaneously [10] . Hypothermia may attenuate secondary biochemical cascades that are activated after acute ischemic injury through reduction of metabolism, perfusion, and edema [10, 11] . On the other hand, reduction of ICP caused by MIH may help improve perfusion. Compared to a head cooling mechanism whole body cooling appears a more suitable system as it was shown that RhinoChill, for example, has effects like epistaxis, cold-related tissue damage, emphysema, hypertension, hypoxia, and the probe placement can be troublesome in critically ill patients. While early studies suggested a reduction in mortality and improved neurological function after TBI after 48 hours of MIH [12] . The BrainHypothermia trial showed no improvement in neurological outcomes or risk of mortality in severe TBI patients compared to patients who were maintained normothermic [13] . In our case, MIH failed to induce any significant reduction in ICP. ICP remained elevated throughout the entire course of hypothermia protocol, which raises concerns about the effectiveness of MIH in lowering ICP in patients with severe TBI who are already in a medically-induced coma.
Licox system can have some discrepancies in monitoring PbtO 2 , more pronounced at extremes of temperatures. The effect of temperature ranges on the accuracy of measurement of PbtO 2 has also been studied. The difference in measurements of PbtO 2 , temperature, and ICP can be observed with different devices used for monitoring. A study to assess accuracy and response time of PbtO 2 probe and the automated card calibration system over a broad range of PbtO 2 values and temperature reported that the probe is overall accurate but may under-estimate oxygen tension at a higher temperature and vice versa [14] . Licox PMO probe has a small tendency to underestimate oxygen tension (mean error, -3.8 ± 3.5%) that is more pronounced between the temperatures of 33 and 39°C [14] . The thermistor of the PMO probe also has a tendency to underestimate temperature when compared with a resistance thermometer (mean error, -0.67 ± 0.22°C) [14] . The card calibrated system was also found to introduce some variability in measurement of oxygen tension when compared with a manually calibrated system [14] . These variations can cause discrepancies when the PbtO 2 probe is used to guide or in conjunction with temperature directed treatment strategies, such as what we have reported.
Conclusion
Our case demonstrates that brain parenchymal oxygenation decreases with a decrease in body temperature. Ensuring adequate cerebral perfusion is of fundamental importance in managing patients with severe TBI. Monitoring brain tissue oxygen tension is becoming more commonly used in conjunction with ICP monitoring in severe TBI. In those patients requiring MIH for control management of refractory intracranial hypertension, it is unknown how robust PbtO 2 values remain. We showed that there is a decrease in PbtO 2 with decreasing temperature even if ICP remains refractory. Future studies should evaluate the clinical significance of this observation.
